R. Thakker, Multiple endocrine neoplasia?syndromes of the twentieth century, J Clin Endocrinol Metab, vol.83, issue.8, pp.2617-2620, 1998.

R. Boni, A. Vortmeyer, S. Pack, W. Park, G. Burg et al., Somatic Mutations of the MEN1 Tumor Suppressor Gene Detected in Sporadic Angiofibromas, Journal of Investigative Dermatology, vol.111, issue.3, pp.539-540, 1998.
DOI : 10.1046/j.1523-1747.1998.00317.x

M. Hofmann, T. Schilling, P. Heilmann, O. Haisken, C. Wuster et al., Multiple endocrine neoplasia type 1 associated with multiple lipomas, Multiple endocrine neoplasia associated with multiple lipomas, pp.546-549, 1998.
DOI : 10.1007/BF03042664

Y. Yang and X. Hua, In search of tumor suppressing functions of menin, Molecular and Cellular Endocrinology, vol.265, issue.266, pp.265-26634, 2007.
DOI : 10.1016/j.mce.2006.12.032

P. Bertolino, I. Radovanovic, H. Casse, A. Aguzzi, Z. Wang et al., Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs, Mechanisms of Development, vol.120, issue.5, pp.549-560, 2003.
DOI : 10.1016/S0925-4773(03)00039-X

P. Bertolino, W. Tong, D. Galendo, Z. Wang, and C. Zhang, Mutant Mice Develop a Range of Endocrine Tumors Mimicking Multiple Endocrine Neoplasia Type 1, Molecular Endocrinology, vol.17, issue.9, pp.1880-1892, 2003.
DOI : 10.1210/me.2003-0154

J. Crabtree, P. Scacheri, J. Ward, L. Garrett-beal, M. Emmert-buck et al., A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors, Proceedings of the National Academy of Sciences, vol.98, issue.3, pp.981118-1123, 2001.
DOI : 10.1073/pnas.98.3.1118

K. Loffler, C. Biondi, M. Gartside, W. P. Stark, M. Serewko-auret et al., Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1, International Journal of Cancer, vol.86, issue.2, pp.259-267, 2007.
DOI : 10.1002/ijc.22288

K. Dreijerink, K. Mulder, G. Winkler, J. Hoppener, C. Lips et al., Menin Links Estrogen Receptor Activation to Histone H3K4 Trimethylation, Cancer Research, vol.66, issue.9, pp.4929-4935, 2006.
DOI : 10.1158/0008-5472.CAN-05-4461

K. Dreijerink, R. Varier, O. Van-beekum, E. Jeninga, J. Hoppener et al., The Multiple Endocrine Neoplasia type 1 (MEN1) tumor suppressor regulates PPAR{gamma}dependent adipocyte differentiation, Mol Cell Biol, issue.18, pp.295060-506901001, 2009.

T. Milne, C. Hughes, R. Lloyd, Z. Yang, O. Rozenblatt-rosen et al., Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors, Proceedings of the National Academy of Sciences, vol.102, issue.3, pp.749-754, 2005.
DOI : 10.1073/pnas.0408836102

S. Karnik, C. Hughes, X. Gu, O. Rozenblatt-rosen, G. Mclean et al., Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c, Proceedings of the National Academy of Sciences, vol.102, issue.41, pp.10214659-14664, 2005.
DOI : 10.1073/pnas.0503484102

S. Shappell, G. Thomas, R. Roberts, R. Herbert, M. Ittmann et al., Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee, Cancer Research, vol.64, issue.6, pp.2270-2305, 2004.
DOI : 10.1158/0008-5472.CAN-03-0946

Y. Liu, J. Mo, Q. Hu, G. Boivin, L. Levin et al., Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer, Cancer Research, vol.68, issue.15, pp.686396-6406, 2008.
DOI : 10.1158/0008-5472.CAN-08-0645

M. Weinstein, S. Signoretti, and M. Loda, Diagnostic Utility of Immunohistochemical Staining for p63, a Sensitive Marker of Prostatic Basal Cells, Modern Pathology, vol.15, issue.12, pp.1302-1308, 2002.
DOI : 10.1097/01.MP.0000038460.95912.6E

T. Tsurusaki, D. Aoki, H. Kanetake, S. Inoue, M. Muramatsu et al., Zone-Dependent Expression of Estrogen Receptors ?? and ?? in Human Benign Prostatic Hyperplasia, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1333-1340, 2003.
DOI : 10.1210/jc.2002-021015

J. Svensson, J. Kindblom, R. Shao, S. Moverare-skrtic, M. Lagerquist et al., Liver-derived IGF1 enhances the androgenic response in prostate, Journal of Endocrinology, vol.199, issue.3, pp.199489-497, 2008.
DOI : 10.1677/JOE-08-0406

K. Ishii, K. Imanaka-yoshida, T. Yoshida, and Y. Sugimura, Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation, Developmental Biology, vol.324, issue.2, pp.310-319, 2008.
DOI : 10.1016/j.ydbio.2008.09.029

D. Cristofano, A. , D. Acetis, M. Koff, A. Cordon-cardo et al., Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse, Nature Genetics, vol.27, issue.2, pp.222-224, 2001.
DOI : 10.1038/84879

E. Macri and M. Loda, Role of p27 in prostate carcinogenesis, Cancer and Metastasis Reviews, vol.17, issue.4, pp.337-344, 1998.
DOI : 10.1023/A:1006133620914

L. Trotman, M. Niki, Z. Dotan, J. Koutcher, D. Cristofano et al., Pten Dose Dictates Cancer Progression in the Prostate, PLoS Biology, vol.101, issue.3, p.59, 2003.
DOI : 10.1371/journal.pbio.0000059.g006

C. Zhong, G. Saribekyan, C. Liao, M. Cohen, and P. Roy-burman, Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate Tumorigenesis, Cancer Research, vol.66, issue.4, pp.2188-2194, 2006.
DOI : 10.1158/0008-5472.CAN-05-3440

R. Bhatia-gaur, A. Donjacour, P. Sciavolino, M. Kim, N. Desai et al., Roles for Nkx3.1 in prostate development and cancer, Genes & Development, vol.13, issue.8, pp.13966-977, 1999.
DOI : 10.1101/gad.13.8.966

M. Kim, R. Cardiff, N. Desai, W. Banach-petrosky, R. Parsons et al., Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis, Proceedings of the National Academy of Sciences, vol.99, issue.5, pp.992884-2889, 2002.
DOI : 10.1073/pnas.042688999

H. Gao, X. Ouyang, W. Banach-petrosky, A. Borowsky, Y. Lin et al., A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis, Proceedings of the National Academy of Sciences, vol.101, issue.49, pp.17204-17209, 2004.
DOI : 10.1073/pnas.0407693101

C. Bowen, L. Bubendorf, H. Voeller, R. Slack, N. Willi et al., Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression, Cancer Research, vol.60, pp.6111-6115, 2000.

P. Paris, S. Sridharan, A. Hittelman, Y. Kobayashi, S. Perner et al., An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer, Prostate Cancer and Prostatic Diseases, vol.61, issue.2, pp.184-91, 2009.
DOI : 10.1038/ng754

H. Imachi, K. Murao, H. Dobashi, M. Bhuyan, X. Cao et al., Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance, Breast Cancer Research and Treatment, vol.2, issue.2, pp.395-407, 2009.
DOI : 10.1016/j.molonc.2008.06.002

H. Kang, K. Huang, S. Chang, W. Ma, W. Lin et al., Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4, Journal of Biological Chemistry, vol.277, issue.46, pp.43749-43756, 2002.
DOI : 10.1074/jbc.M205603200

I. Litvinov, D. Marzo, A. Isaacs, and J. , Is the Achilles??? Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.7, pp.2972-2982, 2003.
DOI : 10.1210/jc.2002-022038

Y. Xu, S. Chen, K. Ross, and S. Balk, Androgens Induce Prostate Cancer Cell Proliferation through Mammalian Target of Rapamycin Activation and Post-transcriptional Increases in Cyclin D Proteins, Cancer Research, vol.66, issue.15, pp.667783-92, 2006.
DOI : 10.1158/0008-5472.CAN-05-4472

M. Matzuk, M. Finegold, J. Su, A. Hsueh, and A. Bradley, ??-lnhibin is a tumour-suppressor gene with gonadal specificity in mice, Nature, vol.360, issue.6402, pp.313-319, 1992.
DOI : 10.1038/360313a0

R. Behringer, M. Finegold, and R. Cate, M??llerian-inhibiting substance function during mammalian sexual development, Cell, vol.79, issue.3, pp.415-425, 1994.
DOI : 10.1016/0092-8674(94)90251-8

M. Matzuk, M. Finegold, Y. Mishina, A. Bradley, and R. Behringer, Synergistic effects of inhibins and mullerian-inhibiting substance on testicular tumorigenesis, Mol Endocrinol, vol.9, issue.10, pp.1337-1345, 1995.

Y. Mishina, R. Rey, M. Finegold, M. Matzuk, N. Josso et al., Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation., Genes & Development, vol.10, issue.20, pp.102577-2587, 1996.
DOI : 10.1101/gad.10.20.2577

D. Franklin, V. Godfrey, O. Brien, D. Deng, C. Xiong et al., Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity, Molecular and Cellular Biology, vol.20, issue.16, pp.6147-6158, 2000.
DOI : 10.1128/MCB.20.16.6147-6158.2000

N. Hussein, J. Lu, H. Casse, S. Fontaniere, A. Morera et al., Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-?? pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice, Endocrine Related Cancer, vol.15, issue.1, pp.217-227, 2008.
DOI : 10.1677/ERC-06-0046

URL : https://hal.archives-ouvertes.fr/hal-00671020

N. Hussein, H. Casse, S. Fontaniere, A. Morera, M. Asensio et al., Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis, European Journal of Cancer, vol.43, issue.2, pp.402-414, 2007.
DOI : 10.1016/j.ejca.2006.08.038

S. Fontaniere, H. Casse, P. Bertolino, and C. Zhang, Analysis of p27Kip1 Expression in Insulinomas Developed in Pancreatic ??-cell Specific Men1 Mutant Mice, Familial Cancer, vol.16, issue.3, pp.49-54, 2006.
DOI : 10.1007/s10689-005-2575-3

G. Thomas, K. Jacobs, M. Yeager, P. Kraft, S. Wacholder et al., Multiple loci identified in a genome-wide association study of prostate cancer, Nature Genetics, vol.95, issue.3, pp.310-315, 2008.
DOI : 10.1210/jc.86.4.1801